On Treatments and Tests Deferred: Preparing for Collateral Damage from COVID-19

Ann Am Thorac Soc. 2020 Nov;17(11):1371-1373. doi: 10.1513/AnnalsATS.202004-387VP.

Authors

Snigdha Jain¹, Lekshmi Santhosh²

Affiliations

¹ Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut; and.
² Division of Pulmonary/Critical Care Medicine, University of California San Francisco, San Francisco, California.

No abstract available

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections / epidemiology*
Coronavirus Infections / prevention & control*
Delayed Diagnosis*
Delivery of Health Care / methods*
Humans
Infection Control / organization & administration
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / prevention & control*
Pulmonary Medicine / trends
SARS-CoV-2
Time-to-Treatment*